BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 24849405)

  • 1. Methanol extract of Antrodia camphorata protects against lipopolysaccharide-induced acute lung injury by suppressing NF-κB and MAPK pathways in mice.
    Huang GJ; Deng JS; Chen CC; Huang CJ; Sung PJ; Huang SS; Kuo YH
    J Agric Food Chem; 2014 Jun; 62(23):5321-9. PubMed ID: 24849405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
    Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
    Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo.
    Chu X; Ci X; Wei M; Yang X; Cao Q; Guan M; Li H; Deng Y; Feng H; Deng X
    J Agric Food Chem; 2012 Apr; 60(15):3947-54. PubMed ID: 22400806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
    Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
    J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
    San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
    Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba extracts attenuate lipopolysaccharide-induced inflammatory responses in acute lung injury by inhibiting the COX-2 and NF-κB pathways.
    Yao X; Chen N; Ma CH; Tao J; Bao JA; Zong-Qi C; Chen ZT; Miao LY
    Chin J Nat Med; 2015 Jan; 13(1):52-8. PubMed ID: 25660288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sangxingtang inhibits the inflammation of LPS-induced acute lung injury in mice by down-regulating the MAPK/NF-κB pathway.
    Zhang TZ; Yang SH; Yao JF; Du J; Yan TH
    Chin J Nat Med; 2015 Dec; 13(12):889-95. PubMed ID: 26721707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
    Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
    Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
    Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
    J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosol attenuates lipopolysaccharide-induced acute lung injury by inhibiting the inflammatory response and maintaining the alveolar capillary barrier.
    Kim YY; Lee S; Kim MJ; Kang BC; Dhakal H; Choi YA; Park PH; Choi H; Shin TY; Choi HG; Kwon TK; Khang D; Kim SH
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):526-533. PubMed ID: 28974441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression.
    Ni YF; Kuai JK; Lu ZF; Yang GD; Fu HY; Wang J; Tian F; Yan XL; Zhao YC; Wang YJ; Jiang T
    J Surg Res; 2011 Jan; 165(1):e29-35. PubMed ID: 21074783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice.
    Bai GZ; Yu HT; Ni YF; Li XF; Zhang ZP; Su K; Lei J; Liu BY; Ke CK; Zhong DX; Wang YJ; Zhao JB
    J Surg Res; 2013 Jun; 182(2):303-11. PubMed ID: 23158409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
    Liu F; Sun GQ; Gao HY; Li RS; Soromou LW; Chen N; Deng YH; Feng HH
    J Surg Res; 2013 Nov; 185(1):300-9. PubMed ID: 23816246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
    Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
    Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scutellaria baicalensis Ameliorates Acute Lung Injury by Suppressing Inflammation In Vitro and In Vivo.
    Chen JJ; Huang CC; Chang HY; Li PY; Liang YC; Deng JS; Huang SS; Huang GJ
    Am J Chin Med; 2017; 45(1):137-157. PubMed ID: 28081626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
    Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
    J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-326 aggravates acute lung injury in septic shock by mediating the NF-κB signaling pathway.
    Wu CT; Huang Y; Pei ZY; Xi X; Zhu GF
    Int J Biochem Cell Biol; 2018 Aug; 101():1-11. PubMed ID: 29727715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
    Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
    Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Butyrate Inhibits the Inflammation of Lipopolysaccharide-Induced Acute Lung Injury in Mice by Regulating the Toll-Like Receptor 4/Nuclear Factor κB Signaling Pathway.
    Liu J; Chang G; Huang J; Wang Y; Ma N; Roy AC; Shen X
    J Agric Food Chem; 2019 Feb; 67(6):1674-1682. PubMed ID: 30661349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.